American Oncology Network- Warrants (20/09/2028) Net Income

The latest net income for AONCW is $-7.6M as of December 2024. That compares with $-7.1M in the prior-year period — down 7.9% year over year. That is below the sector sector average of $89M. Investors often review this figure alongside American Oncology Network- Warrants (20/09/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, AONCW's net income moved from $-7.1M to $-7.6M — a 7.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in American Oncology Network- Warrants (20/09/2028)'s operating scale or balance-sheet position.

Against its sector companies, AONCW currently prints $-7.6M for net income, while the sector average sits near $89M. That is roughly 108.6% below the sector mean. Large gaps often invite a closer look at American Oncology Network- Warrants (20/09/2028)'s growth, margins, and balance sheet.

A net income figure of $-7.6M for AONCW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $89M. Explore the charts below for those layers of context.

After noting AONCW's net income ($-7.6M), review year-over-year change from $-7.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.